| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ANKRD12_0007700 | Intron-Exon-Intron | chr18:9200512-9211782 | chr18:9200514-9211784 | 137 nt | 0.3942 |
| hsa_ANKRD12_0007800 | Intron-Exon-Intron | chr18:9200512-9221997 | chr18:9200514-9221999 | 131 nt | 0.3893 |
| hsa_ANKRD12_0007900 | Intron-Exon-Intron | chr18:9200512-9239554 | chr18:9200514-9239556 | 137 nt | 0.3869 |
| hsa_ANKRD12_0008700 | Exon-Exon | chr18:9204474-9208801 | chr18:9204476-9208803 | 216 nt | 0.4074 |
| hsa_ANKRD12_0008800 | Exon-Exon | chr18:9204474-9216898 | chr18:9204476-9216900 | 560 nt | 0.4018 |
| hsa_ANKRD12_0008900 | Exon-Exon | chr18:9204474-9221963 | chr18:9204476-9221965 | 674 nt | 0.4065 |
| hsa_ANKRD12_0009200 | Exon-Exon | chr18:9204474-9263886 | chr18:9204476-9263888 | 168 nt | 0.4048 |
| hsa_ANKRD12_0008600 | Exon-Exon | chr18:9204474-9282763 | chr18:9204476-9282765 | 250 nt | 0.3120 |
| hsa_ANKRD12_0009300 | Exon-Exon | chr18:9204480-9211782 | chr18:9204482-9211784 | 204 nt | 0.4020 |
| hsa_ANKRD12_0009400 | Exon-Exon | chr18:9204480-9221997 | chr18:9204482-9221999 | 144 nt | 0.4236 |
A study in humans demonstrated that circANKRD12 circANKRD12 was significantly upregulated in the peripheral blood of myocardial infarction patients compared to healthy controls, with RT-qPCR validation showing high diagnostic efficacy as reflected by an area under the curve of 0.7819 in receiver operating characteristic analysis [Li et al. DOI:10.3389/fcvm.2022.810257]. A study in humans demonstrated that the circANKRD12 was identified as a differentially expressed circular RNA in the peripheral blood of myocardial infarction patients and was confirmed in an AC16 cell model [Tian et al. DOI: 10.3390/molecules26041155].